Resuscitative endovascular balloon occlusion of the aorta (REBOA) has recently gained popularity as a minimally invasive alternative to open aortic cross-clamping in the management of patients with non-compressible hemorrhage arising below the diaphragm. The purpose of this review is to provide a description of the technical aspects of REBOA use along with an overview of the current animal and clinical data regarding its use.
No takes yet. Share an insight, caveat, or question.
Osborn et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: